# eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.

> **NCT04990284** · PHASE4 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 106 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Opicapone
- **DRUG:** L-DOPA/DDCI

## Key facts

- **NCT ID:** NCT04990284
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-29
- **Primary completion:** 2023-04-04
- **Final completion:** 2023-04-04
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04990284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04990284, "eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04990284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*